As of 2026-10-17, the Relative Valuation of MacroGenics Inc (MGNX) is (6.14) USD. This relative valuation is based on P/E multiples. With the latest stock price at 3.25 USD, the upside of MacroGenics Inc based on Relative Valuation is -289.0%.
The range of the Relative Valuation is (4.75) - (6.22) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 20.7x - 27.1x | 26.7x |
| Forward P/E multiples | 18.0x - 27.1x | 26.8x |
| Fair Price | (4.75) - (6.22) | (6.14) |
| Upside | -246.2% - -291.4% | -289.0% |
| Date | P/E |
| 2026-10-16 | -14.16 |
| 2026-10-15 | -14.68 |
| 2026-10-14 | -14.42 |
| 2026-10-13 | -14.90 |
| 2026-10-12 | -16.20 |
| 2026-10-09 | -16.29 |
| 2026-10-08 | -15.46 |
| 2026-10-07 | -15.46 |
| 2026-10-06 | -15.86 |
| 2026-10-05 | -16.42 |
| 2026-10-02 | -15.59 |
| 2026-10-01 | -15.68 |
| 2026-09-30 | -16.81 |
| 2026-09-29 | -16.42 |
| 2026-09-28 | -17.68 |
| 2026-09-25 | -16.29 |
| 2026-09-24 | -16.55 |
| 2026-09-23 | -16.55 |
| 2026-09-22 | -17.95 |
| 2026-09-21 | -17.95 |
| 2026-09-18 | -18.03 |
| 2026-09-17 | -17.99 |
| 2026-09-16 | -17.77 |
| 2026-09-15 | -17.60 |
| 2026-09-14 | -18.29 |
| 2026-09-11 | -17.42 |
| 2026-09-10 | -17.29 |
| 2026-09-09 | -17.90 |
| 2026-09-08 | -18.82 |
| 2026-09-04 | -19.17 |
| 2026-09-03 | -18.51 |
| 2026-09-02 | -18.82 |
| 2026-09-01 | -17.60 |
| 2026-08-31 | -17.38 |
| 2026-08-28 | -17.99 |
| 2026-08-27 | -17.77 |
| 2026-08-26 | -17.60 |
| 2026-08-25 | -18.16 |
| 2026-08-24 | -17.51 |
| 2026-08-21 | -17.86 |
| 2026-08-20 | -17.73 |
| 2026-08-19 | -18.16 |
| 2026-08-18 | -17.82 |
| 2026-08-17 | -17.68 |
| 2026-08-14 | -18.38 |
| 2026-08-13 | -17.77 |
| 2026-08-12 | -17.51 |
| 2026-08-11 | -17.07 |
| 2026-08-10 | -17.77 |
| 2026-08-07 | -17.60 |